BIOHARVEST SCIENCES INC.
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
About Bioharvest Sciences
Pharmaceutical Preparations, SIC 2834
BioHarvest Sciences Inc. develops and commercializes botanical compositions, operating primarily through its specialized product sales and contract development and manufacturing organization (CDMO) services. The company focuses on the development, biomanufacturing, and distribution of plant-derived offerings and proprietary ingredient solutions, while providing contract research and development capabilities to commercial clients. Its operations serve consumer health, pharmaceutical, nutraceutical, and life sciences markets seeking standardized active plant ingredients.
The enterprise conducts its business activities and operations across North America and the Middle East, with geographic segments encompassing Canada, the United States, and Israel. Its operational infrastructure includes manufacturing facilities, corporate offices, technology assets, and research facilities across these operational territories. BioHarvest Sciences Inc. maintains its principal executive headquarters in Vancouver, British Columbia, Canada.
Summary of the business section of Bioharvest Sciences's latest annual report, written by StockData.
Company profile
Company
- Legal name
- BIOHARVEST SCIENCES INC.
- Headquarters
- Vancouver, A1
- Address
- 1140 - 625 Howe Street V6C 2T6
- Phone
- (604) 622-1186
- Industry
- Pharmaceutical Preparations
- Incorporated in
- A1
- Fiscal year ends
- December 31
- Auditor
- Ziv Haft, Tel-Aviv, Israel
Stock & identifiers
- Ticker
- BHST
- Exchange
- Nasdaq
- Shares outstanding
- 23M, Dec 31, 2025
- Filer category
- <br>Emerging growth company
- SEC CIK
- 1723464
- CUSIP
- 09076J207
- ISIN
- US09076J2078
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
No recent ownership filings by officers or directors
Bioharvest Sciences's leadership is listed in its proxy statement (Form DEF 14A).
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Oct 28, 2024 | Listing | Registration of securities on an exchange (Form 8-A) |
| Apr 21, 2020 | Name change | Name changed from CANNA-V-CELL SCIENCES INC. to BIOHARVEST SCIENCES INC. |
| Oct 15, 2018 | Name change | Name changed from Midnight Star Ventures Corp. to CANNA-V-CELL SCIENCES INC. |